EP 1100491 A1 20010523 - OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
Title (en)
OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
Title (de)
OPHTHALMOLOGISCHE ZUSAMMENSTELLUNGEN ZUR BEHANDLUNG VON OCULARER HYPERTENSION
Title (fr)
COMPOSITIONS OPHTALMIQUES DESTINEES AU TRAITEMENT DE L'HYPERTENSION OCULAIRE
Publication
Application
Priority
- US 9916374 W 19990720
- US 11995198 A 19980721
Abstract (en)
[origin: WO0004899A1] Combinations of a prostaglandin, prostaglandin derivative, hypotensive lipid derived from a prostaglandin or prostaglandin derivative or an ophthalmologically acceptable salt thereof and a topical carbonic anhydrase inhibitor or an ophthalmologically acceptable salt thereof are particularly useful in the treatment of ocular hypertension and glaucoma. The combinations are characterized by an improved effect and reduced side-effects.
IPC 1-7
IPC 8 full level
C07D 495/04 (2006.01); A61K 9/08 (2006.01); A61K 31/382 (2006.01); A61K 31/54 (2006.01); A61K 31/554 (2006.01); A61K 31/557 (2006.01); A61K 31/5575 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61K 47/36 (2006.01); A61P 27/06 (2006.01); C07D 513/04 (2006.01)
CPC (source: EP)
A61K 31/382 (2013.01); A61K 31/554 (2013.01); A61K 31/557 (2013.01); A61K 45/06 (2013.01); A61P 27/06 (2017.12)
Citation (search report)
See references of WO 0004899A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0004899 A1 20000203; AU 5114499 A 20000214; CA 2337349 A1 20000203; EP 1100491 A1 20010523; JP 2002521333 A 20020716
DOCDB simple family (application)
US 9916374 W 19990720; AU 5114499 A 19990720; CA 2337349 A 19990720; EP 99935726 A 19990720; JP 2000560892 A 19990720